22 October 2021
The Philippines is moving closer to eliminating malaria by 2030, while case notification outcomes for presumptive tuberculosis increased by 25% between 2017 and 2019. For HIV, however, success has been more modest. New infections increased by 214% from 2010 to 2018, and deaths by 220% between 2010 and 2019.
To minimize COVID disruptions, the Global Fund introduced grant flexibilities and C19RM funding for disease programs. Funds were provided in a timely manner and utilized effectively, with a high absorption rate.
The Secretariat needs to improve the design of grants and leverage their catalytic role. There is a need to improve TB/MDR-TB screening and diagnosis, support interventions to address challenges in treatment initiation, improve follow-up of lost patients, and increase monitoring of treatment outcomes.
Despite the Global Fund projecting that the Philippines will become ineligible for malaria grant funding in the 2023-2025 grant cycle, and for all financing by 2028, the country is yet to prepare a comprehensive transition plan.